L Moris, MG Cumberbatch, T Van den Broeck… - European urology, 2020 - Elsevier
Context The optimal treatment for men with high-risk localized or locally advanced prostate cancer (PCa) remains unknown. Objective To perform a systematic review of the existing …
Z Wang, Y Ni, J Chen, G Sun, X Zhang, J Zhao… - World journal of surgical …, 2020 - Springer
Background The optimal treatment for patients with high-risk prostate cancer (PCa) remains a debate and selection of patients to receive proper therapy is still an unsettled question …
Prostate cancer (PCa) is the most common non-dermatologic cancer in the western countries in western countries. High-risk PCa accounts for 15% of the diagnosed cases. In …
Context There is little level 1 evidence regarding the relative efficacy of radical prostatectomy (RP) compared with radiotherapy (RT) combined with androgen deprivation …
Objective To report our intermediate outcomes of the use of focal ablation for treating significant unilateral prostate cancer. This technique was adopted in our center 10 years …
NS Hegemann, A Schlesinger-Raab, U Ganswindt… - Radiation …, 2017 - Springer
Background To investigate the risk of second cancer and radiation induced second cancer following prostate cancer radiotherapy. Methods We compared men with radiotherapy only …
Y Kohjimoto, H Uemura, M Yoshida… - … Journal of Urology, 2024 - Wiley Online Library
This fourth edition of the Japanese Clinical Practice Guidelines for Prostate Cancer 2023 is compiled. It was revised under the leadership of the Japanese Urological Association, with …
Importance Whether surgery or radiotherapy is the preferred treatment for patients with localized prostate cancer continues to be debated, and randomized clinical trials cannot yet …
L Chen, Q Li, Y Wang, Y Zhang, X Ma - Oncotarget, 2017 - ncbi.nlm.nih.gov
Since there was no consensus on treatment options of localized prostate cancer, a meta- analysis was performed to compare the efficacy of radical prostatectomy (RP) versus …